Helmy Eltoukhy is the chairman and co-CEO of the leading precision oncology company Guardant Health, which he co-founded in 2012 with Dr. AmirAli Talasaz. In 2007, Eltoukhy co-founded Avantome to commercialize semiconductor sequencing which was acquired by Illumina. While at Illumina, Eltoukhy served as senior director of Advanced Technology Research, where he developed novel chemistries, hardware, and informatics for genetic analysis systems. Eltoukhy received his PhD, MS and BS degrees in electrical engineering from Stanford University.

Speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.

Panels

Event Panel

The Cancer Diagnostics Revolution

at
Watch